Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990–2017: a population-based study
The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4. However, the indicator is narrowly defined, including only four major NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory dis...
Gespeichert in:
| Veröffentlicht in: | The Lancet global health Jg. 8; H. 4; S. e511 - e523 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Elsevier Ltd
01.04.2020
Elsevier |
| ISSN: | 2214-109X, 2214-109X |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4. However, the indicator is narrowly defined, including only four major NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases) and only for people aged 30–70 years. This study focuses on premature avertable mortality from NCDs—premature deaths caused by NCDs that could be prevented through effective public policies and health interventions or amenable to high-quality health care—to assess trends at global, regional, and national levels using estimates from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2017.
We reviewed existing lists of NCD causes of death that are either preventable through public health policies and interventions or amenable to health care to create a list of avertable NCD causes of death, which was mapped to the GBD cause list. We estimated age-standardised years of life lost (YLL) per 100 000 population due to premature avertable mortality from NCDs, avertable NCD cause clusters, and non-avertable NCD causes by sex, location, and year and reported their 95% uncertainty intervals (UIs). We examined trends in age-standardised YLL due to avertable and non-avertable NCDs, assessed the progress of premature avertable mortality from NCDs in achieving SDG 3.4, and explored specific avertable NCD cause clusters that could make a substantial contribution to overall trends in premature mortality.
Globally, premature avertable mortality from NCDs for both sexes combined declined −1·3% (95% UI −1·4 to −1·2) per year, from 12 855 years (11 809 to 14 051) in 1990 to 9008 years (8329 to 9756) in 2017. However, the absolute number of avertable NCD deaths increased 49·3% (95% UI 47·3 to 52·2) from 23·1 million (22·0–24·1) deaths in 1990 to 34·5 million (33·4 to 35·6) in 2017. Premature avertable mortality from NCDs reduced in every WHO region and in most countries and territories between 1990 and 2017. Despite these reductions, only the Western Pacific and European regions and 25 countries (most of which are high-income countries) are on track to achieve SDG target 3.4. Since 2017, there has been a global slowdown in the reduction of premature avertable mortality from NCDs. In 2017, high premature avertable mortality from NCDs was clustered in low-income and middle-income countries, mainly in the South-East Asia region, Eastern Mediterranean region, and African region. Most countries with large annual reductions in such mortality between 1990 and 2017 had achieved low levels of premature avertable mortality from NCDs by 2017. Some countries, the most populous examples being Afghanistan, the Central African Republic, Uzbekistan, Haiti, Mongolia, Turkmenistan, Pakistan, Ukraine, Laos, and Egypt, reported both an upward trend and high levels of premature avertable mortality from NCDs. Cardiovascular diseases, cancers, and chronic respiratory diseases have been the main drivers of the global and regional reduction in premature avertable mortality from NCDs, whereas premature mortality from substance use disorders, chronic kidney disease and acute glomerulonephritis, and diabetes have been increasing.
Worldwide, there has been a substantial reduction in premature avertable mortality from NCDs, but progress has been uneven across populations. Countries vary substantially in current levels and trends and, hence, the extent to which they are on track to achieve SDG 3.4. By accounting for premature avertable mortality while avoiding arbitrary age cutoffs, premature avertable mortality from NCDs is a robust, comprehensive, and actionable indicator for quantifying and monitoring global and national progress towards NCD prevention and control.
None. |
|---|---|
| AbstractList | The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4. However, the indicator is narrowly defined, including only four major NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases) and only for people aged 30–70 years. This study focuses on premature avertable mortality from NCDs—premature deaths caused by NCDs that could be prevented through effective public policies and health interventions or amenable to high-quality health care—to assess trends at global, regional, and national levels using estimates from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2017.
We reviewed existing lists of NCD causes of death that are either preventable through public health policies and interventions or amenable to health care to create a list of avertable NCD causes of death, which was mapped to the GBD cause list. We estimated age-standardised years of life lost (YLL) per 100 000 population due to premature avertable mortality from NCDs, avertable NCD cause clusters, and non-avertable NCD causes by sex, location, and year and reported their 95% uncertainty intervals (UIs). We examined trends in age-standardised YLL due to avertable and non-avertable NCDs, assessed the progress of premature avertable mortality from NCDs in achieving SDG 3.4, and explored specific avertable NCD cause clusters that could make a substantial contribution to overall trends in premature mortality.
Globally, premature avertable mortality from NCDs for both sexes combined declined −1·3% (95% UI −1·4 to −1·2) per year, from 12 855 years (11 809 to 14 051) in 1990 to 9008 years (8329 to 9756) in 2017. However, the absolute number of avertable NCD deaths increased 49·3% (95% UI 47·3 to 52·2) from 23·1 million (22·0–24·1) deaths in 1990 to 34·5 million (33·4 to 35·6) in 2017. Premature avertable mortality from NCDs reduced in every WHO region and in most countries and territories between 1990 and 2017. Despite these reductions, only the Western Pacific and European regions and 25 countries (most of which are high-income countries) are on track to achieve SDG target 3.4. Since 2017, there has been a global slowdown in the reduction of premature avertable mortality from NCDs. In 2017, high premature avertable mortality from NCDs was clustered in low-income and middle-income countries, mainly in the South-East Asia region, Eastern Mediterranean region, and African region. Most countries with large annual reductions in such mortality between 1990 and 2017 had achieved low levels of premature avertable mortality from NCDs by 2017. Some countries, the most populous examples being Afghanistan, the Central African Republic, Uzbekistan, Haiti, Mongolia, Turkmenistan, Pakistan, Ukraine, Laos, and Egypt, reported both an upward trend and high levels of premature avertable mortality from NCDs. Cardiovascular diseases, cancers, and chronic respiratory diseases have been the main drivers of the global and regional reduction in premature avertable mortality from NCDs, whereas premature mortality from substance use disorders, chronic kidney disease and acute glomerulonephritis, and diabetes have been increasing.
Worldwide, there has been a substantial reduction in premature avertable mortality from NCDs, but progress has been uneven across populations. Countries vary substantially in current levels and trends and, hence, the extent to which they are on track to achieve SDG 3.4. By accounting for premature avertable mortality while avoiding arbitrary age cutoffs, premature avertable mortality from NCDs is a robust, comprehensive, and actionable indicator for quantifying and monitoring global and national progress towards NCD prevention and control.
None. The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4. However, the indicator is narrowly defined, including only four major NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases) and only for people aged 30-70 years. This study focuses on premature avertable mortality from NCDs-premature deaths caused by NCDs that could be prevented through effective public policies and health interventions or amenable to high-quality health care-to assess trends at global, regional, and national levels using estimates from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2017. We reviewed existing lists of NCD causes of death that are either preventable through public health policies and interventions or amenable to health care to create a list of avertable NCD causes of death, which was mapped to the GBD cause list. We estimated age-standardised years of life lost (YLL) per 100 000 population due to premature avertable mortality from NCDs, avertable NCD cause clusters, and non-avertable NCD causes by sex, location, and year and reported their 95% uncertainty intervals (UIs). We examined trends in age-standardised YLL due to avertable and non-avertable NCDs, assessed the progress of premature avertable mortality from NCDs in achieving SDG 3.4, and explored specific avertable NCD cause clusters that could make a substantial contribution to overall trends in premature mortality. Globally, premature avertable mortality from NCDs for both sexes combined declined -1·3% (95% UI -1·4 to -1·2) per year, from 12 855 years (11 809 to 14 051) in 1990 to 9008 years (8329 to 9756) in 2017. However, the absolute number of avertable NCD deaths increased 49·3% (95% UI 47·3 to 52·2) from 23·1 million (22·0-24·1) deaths in 1990 to 34·5 million (33·4 to 35·6) in 2017. Premature avertable mortality from NCDs reduced in every WHO region and in most countries and territories between 1990 and 2017. Despite these reductions, only the Western Pacific and European regions and 25 countries (most of which are high-income countries) are on track to achieve SDG target 3.4. Since 2017, there has been a global slowdown in the reduction of premature avertable mortality from NCDs. In 2017, high premature avertable mortality from NCDs was clustered in low-income and middle-income countries, mainly in the South-East Asia region, Eastern Mediterranean region, and African region. Most countries with large annual reductions in such mortality between 1990 and 2017 had achieved low levels of premature avertable mortality from NCDs by 2017. Some countries, the most populous examples being Afghanistan, the Central African Republic, Uzbekistan, Haiti, Mongolia, Turkmenistan, Pakistan, Ukraine, Laos, and Egypt, reported both an upward trend and high levels of premature avertable mortality from NCDs. Cardiovascular diseases, cancers, and chronic respiratory diseases have been the main drivers of the global and regional reduction in premature avertable mortality from NCDs, whereas premature mortality from substance use disorders, chronic kidney disease and acute glomerulonephritis, and diabetes have been increasing. Worldwide, there has been a substantial reduction in premature avertable mortality from NCDs, but progress has been uneven across populations. Countries vary substantially in current levels and trends and, hence, the extent to which they are on track to achieve SDG 3.4. By accounting for premature avertable mortality while avoiding arbitrary age cutoffs, premature avertable mortality from NCDs is a robust, comprehensive, and actionable indicator for quantifying and monitoring global and national progress towards NCD prevention and control. None. The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4. However, the indicator is narrowly defined, including only four major NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases) and only for people aged 30-70 years. This study focuses on premature avertable mortality from NCDs-premature deaths caused by NCDs that could be prevented through effective public policies and health interventions or amenable to high-quality health care-to assess trends at global, regional, and national levels using estimates from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2017.BACKGROUNDThe reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4. However, the indicator is narrowly defined, including only four major NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases) and only for people aged 30-70 years. This study focuses on premature avertable mortality from NCDs-premature deaths caused by NCDs that could be prevented through effective public policies and health interventions or amenable to high-quality health care-to assess trends at global, regional, and national levels using estimates from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2017.We reviewed existing lists of NCD causes of death that are either preventable through public health policies and interventions or amenable to health care to create a list of avertable NCD causes of death, which was mapped to the GBD cause list. We estimated age-standardised years of life lost (YLL) per 100 000 population due to premature avertable mortality from NCDs, avertable NCD cause clusters, and non-avertable NCD causes by sex, location, and year and reported their 95% uncertainty intervals (UIs). We examined trends in age-standardised YLL due to avertable and non-avertable NCDs, assessed the progress of premature avertable mortality from NCDs in achieving SDG 3.4, and explored specific avertable NCD cause clusters that could make a substantial contribution to overall trends in premature mortality.METHODSWe reviewed existing lists of NCD causes of death that are either preventable through public health policies and interventions or amenable to health care to create a list of avertable NCD causes of death, which was mapped to the GBD cause list. We estimated age-standardised years of life lost (YLL) per 100 000 population due to premature avertable mortality from NCDs, avertable NCD cause clusters, and non-avertable NCD causes by sex, location, and year and reported their 95% uncertainty intervals (UIs). We examined trends in age-standardised YLL due to avertable and non-avertable NCDs, assessed the progress of premature avertable mortality from NCDs in achieving SDG 3.4, and explored specific avertable NCD cause clusters that could make a substantial contribution to overall trends in premature mortality.Globally, premature avertable mortality from NCDs for both sexes combined declined -1·3% (95% UI -1·4 to -1·2) per year, from 12 855 years (11 809 to 14 051) in 1990 to 9008 years (8329 to 9756) in 2017. However, the absolute number of avertable NCD deaths increased 49·3% (95% UI 47·3 to 52·2) from 23·1 million (22·0-24·1) deaths in 1990 to 34·5 million (33·4 to 35·6) in 2017. Premature avertable mortality from NCDs reduced in every WHO region and in most countries and territories between 1990 and 2017. Despite these reductions, only the Western Pacific and European regions and 25 countries (most of which are high-income countries) are on track to achieve SDG target 3.4. Since 2017, there has been a global slowdown in the reduction of premature avertable mortality from NCDs. In 2017, high premature avertable mortality from NCDs was clustered in low-income and middle-income countries, mainly in the South-East Asia region, Eastern Mediterranean region, and African region. Most countries with large annual reductions in such mortality between 1990 and 2017 had achieved low levels of premature avertable mortality from NCDs by 2017. Some countries, the most populous examples being Afghanistan, the Central African Republic, Uzbekistan, Haiti, Mongolia, Turkmenistan, Pakistan, Ukraine, Laos, and Egypt, reported both an upward trend and high levels of premature avertable mortality from NCDs. Cardiovascular diseases, cancers, and chronic respiratory diseases have been the main drivers of the global and regional reduction in premature avertable mortality from NCDs, whereas premature mortality from substance use disorders, chronic kidney disease and acute glomerulonephritis, and diabetes have been increasing.FINDINGSGlobally, premature avertable mortality from NCDs for both sexes combined declined -1·3% (95% UI -1·4 to -1·2) per year, from 12 855 years (11 809 to 14 051) in 1990 to 9008 years (8329 to 9756) in 2017. However, the absolute number of avertable NCD deaths increased 49·3% (95% UI 47·3 to 52·2) from 23·1 million (22·0-24·1) deaths in 1990 to 34·5 million (33·4 to 35·6) in 2017. Premature avertable mortality from NCDs reduced in every WHO region and in most countries and territories between 1990 and 2017. Despite these reductions, only the Western Pacific and European regions and 25 countries (most of which are high-income countries) are on track to achieve SDG target 3.4. Since 2017, there has been a global slowdown in the reduction of premature avertable mortality from NCDs. In 2017, high premature avertable mortality from NCDs was clustered in low-income and middle-income countries, mainly in the South-East Asia region, Eastern Mediterranean region, and African region. Most countries with large annual reductions in such mortality between 1990 and 2017 had achieved low levels of premature avertable mortality from NCDs by 2017. Some countries, the most populous examples being Afghanistan, the Central African Republic, Uzbekistan, Haiti, Mongolia, Turkmenistan, Pakistan, Ukraine, Laos, and Egypt, reported both an upward trend and high levels of premature avertable mortality from NCDs. Cardiovascular diseases, cancers, and chronic respiratory diseases have been the main drivers of the global and regional reduction in premature avertable mortality from NCDs, whereas premature mortality from substance use disorders, chronic kidney disease and acute glomerulonephritis, and diabetes have been increasing.Worldwide, there has been a substantial reduction in premature avertable mortality from NCDs, but progress has been uneven across populations. Countries vary substantially in current levels and trends and, hence, the extent to which they are on track to achieve SDG 3.4. By accounting for premature avertable mortality while avoiding arbitrary age cutoffs, premature avertable mortality from NCDs is a robust, comprehensive, and actionable indicator for quantifying and monitoring global and national progress towards NCD prevention and control.INTERPRETATIONWorldwide, there has been a substantial reduction in premature avertable mortality from NCDs, but progress has been uneven across populations. Countries vary substantially in current levels and trends and, hence, the extent to which they are on track to achieve SDG 3.4. By accounting for premature avertable mortality while avoiding arbitrary age cutoffs, premature avertable mortality from NCDs is a robust, comprehensive, and actionable indicator for quantifying and monitoring global and national progress towards NCD prevention and control.None.FUNDINGNone. Background: The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4. However, the indicator is narrowly defined, including only four major NCDs (cardiovascular diseases, cancer, diabetes, and chronic respiratory diseases) and only for people aged 30–70 years. This study focuses on premature avertable mortality from NCDs—premature deaths caused by NCDs that could be prevented through effective public policies and health interventions or amenable to high-quality health care—to assess trends at global, regional, and national levels using estimates from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2017. Methods: We reviewed existing lists of NCD causes of death that are either preventable through public health policies and interventions or amenable to health care to create a list of avertable NCD causes of death, which was mapped to the GBD cause list. We estimated age-standardised years of life lost (YLL) per 100 000 population due to premature avertable mortality from NCDs, avertable NCD cause clusters, and non-avertable NCD causes by sex, location, and year and reported their 95% uncertainty intervals (UIs). We examined trends in age-standardised YLL due to avertable and non-avertable NCDs, assessed the progress of premature avertable mortality from NCDs in achieving SDG 3.4, and explored specific avertable NCD cause clusters that could make a substantial contribution to overall trends in premature mortality. Findings: Globally, premature avertable mortality from NCDs for both sexes combined declined −1·3% (95% UI −1·4 to −1·2) per year, from 12 855 years (11 809 to 14 051) in 1990 to 9008 years (8329 to 9756) in 2017. However, the absolute number of avertable NCD deaths increased 49·3% (95% UI 47·3 to 52·2) from 23·1 million (22·0–24·1) deaths in 1990 to 34·5 million (33·4 to 35·6) in 2017. Premature avertable mortality from NCDs reduced in every WHO region and in most countries and territories between 1990 and 2017. Despite these reductions, only the Western Pacific and European regions and 25 countries (most of which are high-income countries) are on track to achieve SDG target 3.4. Since 2017, there has been a global slowdown in the reduction of premature avertable mortality from NCDs. In 2017, high premature avertable mortality from NCDs was clustered in low-income and middle-income countries, mainly in the South-East Asia region, Eastern Mediterranean region, and African region. Most countries with large annual reductions in such mortality between 1990 and 2017 had achieved low levels of premature avertable mortality from NCDs by 2017. Some countries, the most populous examples being Afghanistan, the Central African Republic, Uzbekistan, Haiti, Mongolia, Turkmenistan, Pakistan, Ukraine, Laos, and Egypt, reported both an upward trend and high levels of premature avertable mortality from NCDs. Cardiovascular diseases, cancers, and chronic respiratory diseases have been the main drivers of the global and regional reduction in premature avertable mortality from NCDs, whereas premature mortality from substance use disorders, chronic kidney disease and acute glomerulonephritis, and diabetes have been increasing. Interpretation: Worldwide, there has been a substantial reduction in premature avertable mortality from NCDs, but progress has been uneven across populations. Countries vary substantially in current levels and trends and, hence, the extent to which they are on track to achieve SDG 3.4. By accounting for premature avertable mortality while avoiding arbitrary age cutoffs, premature avertable mortality from NCDs is a robust, comprehensive, and actionable indicator for quantifying and monitoring global and national progress towards NCD prevention and control. Funding: None. |
| Author | Martinez, Ramon Lloyd-Sherlock, Peter Vega, Enrique Soliz, Patricia McKee, Martin Ebrahim, Shah Ordunez, Pedro |
| Author_xml | – sequence: 1 givenname: Ramon surname: Martinez fullname: Martinez, Ramon organization: Pan American Health Organization, Washington, DC, USA – sequence: 2 givenname: Peter surname: Lloyd-Sherlock fullname: Lloyd-Sherlock, Peter email: p.lloyd-sherlock@uea.ac.uk organization: School of International Development, University of East Anglia, Norwich, UK – sequence: 3 givenname: Patricia surname: Soliz fullname: Soliz, Patricia organization: Pan American Health Organization, Washington, DC, USA – sequence: 4 givenname: Shah surname: Ebrahim fullname: Ebrahim, Shah organization: London School of Hygiene & Tropical Medicine, London, UK – sequence: 5 givenname: Enrique surname: Vega fullname: Vega, Enrique organization: Pan American Health Organization, Washington, DC, USA – sequence: 6 givenname: Pedro surname: Ordunez fullname: Ordunez, Pedro organization: Pan American Health Organization, Washington, DC, USA – sequence: 7 givenname: Martin surname: McKee fullname: McKee, Martin organization: London School of Hygiene & Tropical Medicine, London, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32199120$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNUk1v1DAQjVARLaU_AeRjkQj4I7uJQQhVFR-VKnGgSNysyXiCXJJ4azuV9tZ_wIF_yC_Bmy0r1EvxxeOZ997Y8_y42Bv9SEXxVPCXgovlqy9SiqoUXH87lvy54lwtyuZBcbBL7_0T7xdHMV7yvLRWsq4fFftKCq2F5AfFz4tAo43MjWwVaIA0BWJwTSFB2xMbfA56l9asC35g-Rol-mGYRodz3bpIECmyzgcm9IKhn8YUXM7AaFmiEFzym_OLXNb8980vyUX9mgFb-dXUQ3JZss0SlsU02fWT4mEHfaSj2_2w-Prh_cXpp_L888ez05PzEhe6SeWS06KroZVtBarioDjUlUCxbDTXZImr_DwQCFChxlaT5NR12HYENceO1GFxttW1Hi7NKrgBwtp4cGZO-PDdQEgOezKtUAi2ye2WXaWtaCzWFTTAW6mxqUTWOt5qrYK_migmM7iI1Pcwkp-ikaoRSymk0hn67BY6tQPZXeO_hmTAYgvA4GMM1O0ggpuN92b23myMNZKb2XvTZN6bOzx0aZ5uCuD6e9nvtmzKI792FExERyOSdYEw5Zm4exXe3lHA3m1-Sf-D1v_B_wNT-d4Z |
| CitedBy_id | crossref_primary_10_3389_fpubh_2023_1252110 crossref_primary_10_1002_adma_202304963 crossref_primary_10_3389_fnhum_2022_995534 crossref_primary_10_1002_ijgo_13334 crossref_primary_10_1016_j_jshs_2023_09_012 crossref_primary_10_1186_s12939_023_01958_8 crossref_primary_10_1111_jgs_17982 crossref_primary_10_1016_j_jbc_2023_104639 crossref_primary_10_1177_20503121241290385 crossref_primary_10_3390_nu12102995 crossref_primary_10_1016_j_scib_2025_08_037 crossref_primary_10_1016_j_lana_2021_100035 crossref_primary_10_7717_peerj_11307 crossref_primary_10_1136_bmjgh_2021_007132 crossref_primary_10_1186_s12889_024_20186_5 crossref_primary_10_1002_cncr_33586 crossref_primary_10_1016_j_prenap_2025_100299 crossref_primary_10_15829_1728_8800_2023_3712 crossref_primary_10_3390_nu13124472 crossref_primary_10_1016_j_cegh_2022_101174 crossref_primary_10_1016_S0140_6736_23_01573_8 crossref_primary_10_1111_tmi_14134 crossref_primary_10_3390_ijerph20032004 crossref_primary_10_1186_s12913_022_07816_7 crossref_primary_10_1177_21501319221135949 crossref_primary_10_1136_bmjopen_2023_083013 crossref_primary_10_1371_journal_pone_0245241 crossref_primary_10_1007_s13410_020_00875_8 crossref_primary_10_1186_s12889_024_19947_z crossref_primary_10_1017_S1463423622000639 crossref_primary_10_1111_jch_13922 crossref_primary_10_1186_s12961_022_00829_y crossref_primary_10_1136_bmjopen_2021_056262 crossref_primary_10_1186_s12889_023_15598_8 crossref_primary_10_1016_j_imr_2020_100469 crossref_primary_10_1016_j_ejim_2023_07_008 crossref_primary_10_1136_bmjgh_2024_015053 crossref_primary_10_1093_ndt_gfac017 crossref_primary_10_1097_TP_0000000000004186 crossref_primary_10_1186_s12909_023_04999_3 crossref_primary_10_2217_epi_2020_0188 crossref_primary_10_1038_s41591_023_02769_8 crossref_primary_10_1016_j_lanwpc_2023_100938 crossref_primary_10_1186_s41043_025_00827_0 crossref_primary_10_1016_j_mmm_2020_05_008 crossref_primary_10_1016_j_jval_2022_12_008 crossref_primary_10_1007_s44155_022_00021_1 crossref_primary_10_1093_ije_dyac011 crossref_primary_10_1038_s41591_022_01890_4 crossref_primary_10_1016_j_jnha_2025_100504 crossref_primary_10_1136_bmjgh_2021_005838 crossref_primary_10_1136_bmjgh_2021_006189 crossref_primary_10_1371_journal_pone_0298696 crossref_primary_10_3389_fpubh_2022_753861 crossref_primary_10_3390_ijerph18137091 crossref_primary_10_1590_1414_462x202331030615 crossref_primary_10_1111_jog_15019 crossref_primary_10_1111_1753_0407_13159 crossref_primary_10_3390_nu15020415 crossref_primary_10_1007_s13280_021_01693_w crossref_primary_10_1016_j_jstrokecerebrovasdis_2020_105321 crossref_primary_10_1007_s11356_022_20442_4 crossref_primary_10_1016_j_archger_2024_105474 crossref_primary_10_3390_jfmk10020135 crossref_primary_10_3389_fendo_2025_1631123 crossref_primary_10_1016_j_lana_2025_101017 crossref_primary_10_1038_s41598_025_94174_z crossref_primary_10_3322_caac_21706 crossref_primary_10_1111_jch_14157 crossref_primary_10_1016_j_foodres_2020_109844 crossref_primary_10_1186_s12889_023_17457_y crossref_primary_10_3390_nu14030516 crossref_primary_10_1007_s10072_024_07329_7 crossref_primary_10_1016_j_cct_2025_107833 crossref_primary_10_1080_09540121_2025_2494792 crossref_primary_10_1186_s12982_025_00449_1 crossref_primary_10_1016_j_neuron_2021_09_011 crossref_primary_10_4081_hls_2024_12927 crossref_primary_10_1016_j_jnha_2025_100525 crossref_primary_10_1038_s41598_023_40595_7 crossref_primary_10_1038_s41598_024_58554_1 crossref_primary_10_1186_s12889_022_14552_4 crossref_primary_10_5334_gh_1077 crossref_primary_10_1016_j_numecd_2022_11_005 crossref_primary_10_7759_cureus_82233 crossref_primary_10_1093_her_cyad001 crossref_primary_10_1590_s1679_49742020000500016 crossref_primary_10_1016_S2468_2667_20_30204_8 crossref_primary_10_1136_bmjgh_2023_012804 crossref_primary_10_3389_fdgth_2023_1039171 crossref_primary_10_1016_j_socscimed_2021_114194 crossref_primary_10_4103_jfmpc_jfmpc_1697_24 crossref_primary_10_1038_s41390_020_01291_8 crossref_primary_10_1371_journal_pcbi_1010726 crossref_primary_10_1002_wmh3_70002 crossref_primary_10_1016_j_jaim_2023_100831 crossref_primary_10_3389_fpubh_2025_1608525 crossref_primary_10_1080_09593985_2025_2507208 crossref_primary_10_1016_j_cardfail_2022_09_002 crossref_primary_10_1097_MLR_0000000000001694 crossref_primary_10_1136_bmjopen_2024_088338 crossref_primary_10_1136_bmjopen_2021_049767 crossref_primary_10_1371_journal_pone_0303085 crossref_primary_10_1136_bmjopen_2022_062222 crossref_primary_10_3390_healthcare10102095 crossref_primary_10_1016_j_archger_2025_105861 crossref_primary_10_1080_20523211_2024_2404080 crossref_primary_10_1038_s41598_021_99392_9 crossref_primary_10_1039_D5FO01999K crossref_primary_10_1155_2024_7350661 crossref_primary_10_1186_s12939_022_01683_8 crossref_primary_10_3390_nu14020245 crossref_primary_10_1371_journal_pone_0265913 crossref_primary_10_3389_fpubh_2023_1280532 crossref_primary_10_1016_S0140_6736_24_01050_X crossref_primary_10_3390_ijerph22060881 crossref_primary_10_3389_fnut_2022_871062 crossref_primary_10_3389_fnut_2022_951564 crossref_primary_10_1097_MD_0000000000029458 crossref_primary_10_4081_hls_2024_12605 crossref_primary_10_4081_jphr_2021_2921 crossref_primary_10_1007_s00127_025_02828_0 crossref_primary_10_1016_j_jstrokecerebrovasdis_2020_105089 crossref_primary_10_2471_BLT_20_254110 crossref_primary_10_1016_j_pcad_2022_10_001 crossref_primary_10_1016_j_ygyno_2020_07_008 crossref_primary_10_3389_fpubh_2022_1036058 crossref_primary_10_1139_apnm_2020_0588 crossref_primary_10_1590_0102_311xen178723 |
| Cites_doi | 10.1016/S0140-6736(18)31668-4 10.1016/S0140-6736(18)31992-5 10.1016/S0140-6736(18)32278-5 10.1377/hlthaff.2011.0851 10.1111/j.1753-6405.2009.00342.x 10.1016/S0140-6736(15)61016-9 10.1093/ije/dyx243 10.1016/S0140-6736(18)30994-2 10.1186/1478-7954-10-1 10.1377/hlthaff.27.1.58 10.1016/j.healthpol.2017.03.017 10.1016/S0140-6736(18)32203-7 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z 10.1093/ije/dyy254 10.1056/NEJM198005153022012 10.1056/NEJM197603112941104 10.1016/S0140-6736(19)30427-1 10.1016/S2214-109X(19)30069-5 10.1016/S0140-6736(18)31485-5 10.1136/bmj.292.6516.295 10.1016/j.healthpol.2011.08.002 10.1016/S0140-6736(16)30388-9 |
| ContentType | Journal Article |
| Copyright | 2020 Pan American Health Organization. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Copyright © 2020 Pan American Health Organization. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. |
| Copyright_xml | – notice: 2020 Pan American Health Organization. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license – notice: Copyright © 2020 Pan American Health Organization. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 DOA |
| DOI | 10.1016/S2214-109X(20)30035-8 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health |
| EISSN | 2214-109X |
| EndPage | e523 |
| ExternalDocumentID | oai_doaj_org_article_b13cad8f7a6f49d18dc74a8a0b29c841 32199120 10_1016_S2214_109X_20_30035_8 S2214109X20300358 |
| Genre | Journal Article |
| GrantInformation | None. |
| GroupedDBID | .1- .FO 0R~ 1P~ 457 53G AAEDT AAEDW AAIKJ AALRI AAMRU AAXUO AAYWO ABMAC ACGFS ACHQT ACVFH ADBBV ADCNI ADEZE ADVLN AENEX AEUPX AEVXI AEXQZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP BAWUL BCNDV DIK EBS EJD FDB GROUPED_DOAJ HZ~ IPNFZ IXB KQ8 M41 M~E O9- OD. OK1 OO~ RIG ROL SSZ Z5R 0SF 6I. AACTN AAFTH AFCTW NCXOZ AAYXX CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c598t-60e5f7ab2b4a340a30a741c168909ede03912a1caa4c9cb9e20effcbfea70cfe3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 156 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000521078600023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2214-109X |
| IngestDate | Fri Oct 03 12:49:17 EDT 2025 Fri Jul 11 09:48:01 EDT 2025 Thu Jan 02 22:59:30 EST 2025 Wed Nov 05 20:38:53 EST 2025 Tue Nov 18 22:25:54 EST 2025 Wed May 17 00:10:30 EDT 2023 Tue Aug 26 16:32:28 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2020 Pan American Health Organization. Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c598t-60e5f7ab2b4a340a30a741c168909ede03912a1caa4c9cb9e20effcbfea70cfe3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/b13cad8f7a6f49d18dc74a8a0b29c841 |
| PMID | 32199120 |
| PQID | 2381621239 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_b13cad8f7a6f49d18dc74a8a0b29c841 proquest_miscellaneous_2381621239 pubmed_primary_32199120 crossref_primary_10_1016_S2214_109X_20_30035_8 crossref_citationtrail_10_1016_S2214_109X_20_30035_8 elsevier_sciencedirect_doi_10_1016_S2214_109X_20_30035_8 elsevier_clinicalkey_doi_10_1016_S2214_109X_20_30035_8 |
| PublicationCentury | 2000 |
| PublicationDate | April 2020 2020-04-00 2020-Apr 20200401 2020-04-01 |
| PublicationDateYYYYMMDD | 2020-04-01 |
| PublicationDate_xml | – month: 04 year: 2020 text: April 2020 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | The Lancet global health |
| PublicationTitleAlternate | Lancet Glob Health |
| PublicationYear | 2020 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Stevens, Alkema, Black (bib32) 2016; 388 Charlton, Velez (bib7) 1986; 292 Tobias, Yeh (bib9) 2009; 33 Nolte, McKee (bib14) 2004 Lloyd-Sherlock, Ebrahim, Martinez, McKee, Ordunez (bib4) 2019; 7 Foreman, Lozano, Lopez, Murray (bib37) 2012; 10 Roth, Abate, Abate (bib23) 2018; 392 Nolte, McKee (bib13) 2012; 31 Nolte, McKee (bib11) 2011; 103 Zhou, Wang, Zeng (bib33) 2019; 394 Tobias (bib21) Gay, Paris, Devaux, de Looper (bib10) 2011 (bib24) 2019; 92 Ahmad, Boschi-Pinto, Lopez (bib28) 2001 Das Gupta (bib31) (bib26) 2018; 392 Weber, Clerc (bib17) 2017; 121 Rutstein, Berenberg, Chalmers, Fishman, Perrin, Zuidema (bib8) 1980; 302 Lloyd-Sherlock, Ebrahim, McKee, Prince (bib3) 2015; 385 Nolte, McKee (bib12) 2008; 27 (bib5) 2018; 392 Nosrati, Ash, Marmot, McKee, King (bib35) 2017; 47 bib22 Fullman, Yearwood, Abay (bib15) 2018; 391 bib18 Franco-Marina, Lozano, Villa, Soliz (bib19) 2006 Carvalho Malta, Duarte, Furquim de Almeida (bib20) 2007; 16 (bib27) 2018 bib1 bib2 Kruk, Gage, Joseph, Danaei, García-Saisó, Salomon (bib16) 2018; 392 Kim, Fay, Feuer, Midthune (bib30) 2000; 19 (bib36) 2018; 63 Martinez, Soliz, Caixeta, Ordunez (bib25) 2019; 48 Starodubov, Marczak, Varavikova (bib34) 2018; 392 Rutstein, Berenberg, Chalmers (bib6) 1976; 294 Rutstein (10.1016/S2214-109X(20)30035-8_bib6) 1976; 294 Gay (10.1016/S2214-109X(20)30035-8_bib10) 2011 Martinez (10.1016/S2214-109X(20)30035-8_bib25) 2019; 48 Ahmad (10.1016/S2214-109X(20)30035-8_bib28) Charlton (10.1016/S2214-109X(20)30035-8_bib7) 1986; 292 Nolte (10.1016/S2214-109X(20)30035-8_bib12) 2008; 27 Stevens (10.1016/S2214-109X(20)30035-8_bib32) 2016; 388 Weber (10.1016/S2214-109X(20)30035-8_bib17) 2017; 121 Nosrati (10.1016/S2214-109X(20)30035-8_bib35) 2017; 47 Fullman (10.1016/S2214-109X(20)30035-8_bib15) 2018; 391 (10.1016/S2214-109X(20)30035-8_bib24) 2019; 92 Tobias (10.1016/S2214-109X(20)30035-8_bib21) Lloyd-Sherlock (10.1016/S2214-109X(20)30035-8_bib3) 2015; 385 Kim (10.1016/S2214-109X(20)30035-8_bib30) 2000; 19 (10.1016/S2214-109X(20)30035-8_bib36) 2018; 63 Lloyd-Sherlock (10.1016/S2214-109X(20)30035-8_bib4) 2019; 7 Tobias (10.1016/S2214-109X(20)30035-8_bib9) 2009; 33 Das Gupta (10.1016/S2214-109X(20)30035-8_bib31) Nolte (10.1016/S2214-109X(20)30035-8_bib14) 2004 Rutstein (10.1016/S2214-109X(20)30035-8_bib8) 1980; 302 (10.1016/S2214-109X(20)30035-8_bib5) 2018; 392 Roth (10.1016/S2214-109X(20)30035-8_bib23) 2018; 392 Zhou (10.1016/S2214-109X(20)30035-8_bib33) 2019; 394 Franco-Marina (10.1016/S2214-109X(20)30035-8_bib19) 2006 Nolte (10.1016/S2214-109X(20)30035-8_bib11) 2011; 103 Foreman (10.1016/S2214-109X(20)30035-8_bib37) 2012; 10 Nolte (10.1016/S2214-109X(20)30035-8_bib13) 2012; 31 Carvalho Malta (10.1016/S2214-109X(20)30035-8_bib20) 2007; 16 Kruk (10.1016/S2214-109X(20)30035-8_bib16) 2018; 392 Starodubov (10.1016/S2214-109X(20)30035-8_bib34) 2018; 392 (10.1016/S2214-109X(20)30035-8_bib26) 2018; 392 |
| References_xml | – ident: bib2 article-title: Transforming our world: the 2030 agenda for sustainable development. 2015 – volume: 33 start-page: 70 year: 2009 end-page: 78 ident: bib9 article-title: How much does health care contribute to health gain and to health inequality? Trends in amenable mortality in New Zealand 1981–2004 publication-title: Aust NZ J Public Health – ident: bib1 article-title: NCD global monitoring framework. 2013 – ident: bib18 article-title: Health Indicators 2012. 2012 – ident: bib21 article-title: Defining amenable mortality. September, 2016 – volume: 388 start-page: e19 year: 2016 end-page: e23 ident: bib32 article-title: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement publication-title: Lancet – volume: 391 start-page: 2236 year: 2018 end-page: 2271 ident: bib15 article-title: Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 publication-title: Lancet – volume: 294 start-page: 582 year: 1976 end-page: 588 ident: bib6 article-title: Measuring the quality of medical care. A clinical method publication-title: N Engl J Med – volume: 31 start-page: 2114 year: 2012 end-page: 2122 ident: bib13 article-title: In amenable mortality—deaths avoidable through health care—progress in the US lags that of three European countries publication-title: Health Aff (Millwood) – year: 2001 ident: bib28 article-title: Age standardization of rates: a new WHO standard – volume: 92 start-page: 1684 year: 2019 end-page: 1735 ident: bib24 article-title: Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet – volume: 121 start-page: 644 year: 2017 end-page: 652 ident: bib17 article-title: Deaths amenable to health care: converging trends in the EU? publication-title: Health Policy – volume: 27 start-page: 58 year: 2008 end-page: 71 ident: bib12 article-title: Measuring the health of nations: updating an earlier analysis publication-title: Health Aff (Millwood) – volume: 48 start-page: 1367 year: 2019 end-page: 1376 ident: bib25 article-title: Reflection on modern methods: years of life lost due to premature mortality—a versatile and comprehensive measure for monitoring non-communicable disease mortality publication-title: Int J Epidemiol – ident: bib22 article-title: Global Burden of Disease study 2017 (GBD 2017) causes of death and nonfatal causes mapped to ICD codes. 2018 – volume: 103 start-page: 47 year: 2011 end-page: 52 ident: bib11 article-title: Variations in amenable mortality—trends in 16 high-income nations publication-title: Health Policy – volume: 292 start-page: 295 year: 1986 end-page: 301 ident: bib7 article-title: Some international comparisons of mortality amenable to medical intervention publication-title: Br Med J (Clin Res Ed) – volume: 392 start-page: 1995 year: 2018 end-page: 2051 ident: bib26 article-title: Population and fertility by age and sex for 195 countries, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet – year: 2011 ident: bib10 publication-title: Mortality amenable to health care in 31 OECD countries – volume: 10 start-page: 1 year: 2012 ident: bib37 article-title: Modeling causes of death: an integrated approach using CODEm publication-title: Popul Health Metr – year: 2018 ident: bib27 article-title: Global Burden of Disease study 2017 (GBD 2017) population estimates 1950−2017 – volume: 19 start-page: 335 year: 2000 end-page: 351 ident: bib30 article-title: Permutation tests for joinpoint regression with applications to cancer rates publication-title: Stat Med – volume: 394 start-page: 1145 year: 2019 end-page: 1158 ident: bib33 article-title: Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet – volume: 47 start-page: 720 year: 2017 end-page: 730 ident: bib35 article-title: The association between income and life expectancy revisited: deindustrialization, incarceration and the widening health gap publication-title: Int J Epidemiol – volume: 392 start-page: 1072 year: 2018 end-page: 1088 ident: bib5 article-title: NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4 publication-title: Lancet – year: 2006 ident: bib19 publication-title: La Mortalidad en México, 2000−2004 “Muertes Evitables: magnitud, distribución y tendencias” – volume: 392 start-page: 2203 year: 2018 end-page: 2212 ident: bib16 article-title: Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries publication-title: Lancet – volume: 7 start-page: e604 year: 2019 end-page: e612 ident: bib4 article-title: Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15 publication-title: Lancet Glob Health – volume: 392 start-page: 1736 year: 2018 end-page: 1788 ident: bib23 article-title: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet – volume: 302 start-page: 1146 year: 1980 ident: bib8 article-title: Measuring the quality of medical care: second revision of tables of indexes publication-title: N Engl J Med – volume: 16 start-page: 233 year: 2007 end-page: 244 ident: bib20 article-title: List of avoidable causes of deaths due to interventions of the Brazilian Health System. publication-title: Saúde, Brasília – volume: 392 start-page: 1138 year: 2018 end-page: 1146 ident: bib34 article-title: The burden of disease in Russia from 1980 to 2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet – volume: 63 start-page: S11 year: 2018 end-page: S23 ident: bib36 article-title: Danger ahead: the burden of diseases, injuries, and risk factors in the Eastern Mediterranean Region, 1990–2015 publication-title: Int J Public Health – year: 2004 ident: bib14 publication-title: Does healthcare save lives? Avoidable mortality revisited – volume: 385 start-page: 2147 year: 2015 end-page: 2148 ident: bib3 article-title: A premature mortality target for the SDG for health is ageist publication-title: Lancet – ident: bib31 article-title: Standardization and decomposition of rates: a user's manual. US Department of Commerce. Bureau of Census. 1993 – ident: 10.1016/S2214-109X(20)30035-8_bib21 – year: 2011 ident: 10.1016/S2214-109X(20)30035-8_bib10 – volume: 392 start-page: 2203 year: 2018 ident: 10.1016/S2214-109X(20)30035-8_bib16 article-title: Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries publication-title: Lancet doi: 10.1016/S0140-6736(18)31668-4 – volume: 392 start-page: 1072 year: 2018 ident: 10.1016/S2214-109X(20)30035-8_bib5 article-title: NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4 publication-title: Lancet doi: 10.1016/S0140-6736(18)31992-5 – volume: 392 start-page: 1995 year: 2018 ident: 10.1016/S2214-109X(20)30035-8_bib26 article-title: Population and fertility by age and sex for 195 countries, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet doi: 10.1016/S0140-6736(18)32278-5 – volume: 31 start-page: 2114 year: 2012 ident: 10.1016/S2214-109X(20)30035-8_bib13 article-title: In amenable mortality—deaths avoidable through health care—progress in the US lags that of three European countries publication-title: Health Aff (Millwood) doi: 10.1377/hlthaff.2011.0851 – ident: 10.1016/S2214-109X(20)30035-8_bib31 – volume: 33 start-page: 70 year: 2009 ident: 10.1016/S2214-109X(20)30035-8_bib9 article-title: How much does health care contribute to health gain and to health inequality? Trends in amenable mortality in New Zealand 1981–2004 publication-title: Aust NZ J Public Health doi: 10.1111/j.1753-6405.2009.00342.x – ident: 10.1016/S2214-109X(20)30035-8_bib28 – volume: 385 start-page: 2147 year: 2015 ident: 10.1016/S2214-109X(20)30035-8_bib3 article-title: A premature mortality target for the SDG for health is ageist publication-title: Lancet doi: 10.1016/S0140-6736(15)61016-9 – volume: 16 start-page: 233 year: 2007 ident: 10.1016/S2214-109X(20)30035-8_bib20 article-title: List of avoidable causes of deaths due to interventions of the Brazilian Health System. Epidemiol. Serv publication-title: Saúde, Brasília – volume: 47 start-page: 720 year: 2017 ident: 10.1016/S2214-109X(20)30035-8_bib35 article-title: The association between income and life expectancy revisited: deindustrialization, incarceration and the widening health gap publication-title: Int J Epidemiol doi: 10.1093/ije/dyx243 – volume: 63 start-page: S11 issue: suppl 1 year: 2018 ident: 10.1016/S2214-109X(20)30035-8_bib36 article-title: Danger ahead: the burden of diseases, injuries, and risk factors in the Eastern Mediterranean Region, 1990–2015 publication-title: Int J Public Health – volume: 391 start-page: 2236 year: 2018 ident: 10.1016/S2214-109X(20)30035-8_bib15 article-title: Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 publication-title: Lancet doi: 10.1016/S0140-6736(18)30994-2 – year: 2006 ident: 10.1016/S2214-109X(20)30035-8_bib19 – volume: 10 start-page: 1 year: 2012 ident: 10.1016/S2214-109X(20)30035-8_bib37 article-title: Modeling causes of death: an integrated approach using CODEm publication-title: Popul Health Metr doi: 10.1186/1478-7954-10-1 – year: 2004 ident: 10.1016/S2214-109X(20)30035-8_bib14 – volume: 27 start-page: 58 year: 2008 ident: 10.1016/S2214-109X(20)30035-8_bib12 article-title: Measuring the health of nations: updating an earlier analysis publication-title: Health Aff (Millwood) doi: 10.1377/hlthaff.27.1.58 – volume: 121 start-page: 644 year: 2017 ident: 10.1016/S2214-109X(20)30035-8_bib17 article-title: Deaths amenable to health care: converging trends in the EU? publication-title: Health Policy doi: 10.1016/j.healthpol.2017.03.017 – volume: 392 start-page: 1736 year: 2018 ident: 10.1016/S2214-109X(20)30035-8_bib23 article-title: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet doi: 10.1016/S0140-6736(18)32203-7 – volume: 19 start-page: 335 year: 2000 ident: 10.1016/S2214-109X(20)30035-8_bib30 article-title: Permutation tests for joinpoint regression with applications to cancer rates publication-title: Stat Med doi: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z – volume: 48 start-page: 1367 year: 2019 ident: 10.1016/S2214-109X(20)30035-8_bib25 article-title: Reflection on modern methods: years of life lost due to premature mortality—a versatile and comprehensive measure for monitoring non-communicable disease mortality publication-title: Int J Epidemiol doi: 10.1093/ije/dyy254 – volume: 302 start-page: 1146 year: 1980 ident: 10.1016/S2214-109X(20)30035-8_bib8 article-title: Measuring the quality of medical care: second revision of tables of indexes publication-title: N Engl J Med doi: 10.1056/NEJM198005153022012 – volume: 294 start-page: 582 year: 1976 ident: 10.1016/S2214-109X(20)30035-8_bib6 article-title: Measuring the quality of medical care. A clinical method publication-title: N Engl J Med doi: 10.1056/NEJM197603112941104 – volume: 92 start-page: 1684 year: 2019 ident: 10.1016/S2214-109X(20)30035-8_bib24 article-title: Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet – volume: 394 start-page: 1145 year: 2019 ident: 10.1016/S2214-109X(20)30035-8_bib33 article-title: Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet doi: 10.1016/S0140-6736(19)30427-1 – volume: 7 start-page: e604 year: 2019 ident: 10.1016/S2214-109X(20)30035-8_bib4 article-title: Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15 publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(19)30069-5 – volume: 392 start-page: 1138 year: 2018 ident: 10.1016/S2214-109X(20)30035-8_bib34 article-title: The burden of disease in Russia from 1980 to 2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet doi: 10.1016/S0140-6736(18)31485-5 – volume: 292 start-page: 295 year: 1986 ident: 10.1016/S2214-109X(20)30035-8_bib7 article-title: Some international comparisons of mortality amenable to medical intervention publication-title: Br Med J (Clin Res Ed) doi: 10.1136/bmj.292.6516.295 – volume: 103 start-page: 47 year: 2011 ident: 10.1016/S2214-109X(20)30035-8_bib11 article-title: Variations in amenable mortality—trends in 16 high-income nations publication-title: Health Policy doi: 10.1016/j.healthpol.2011.08.002 – volume: 388 start-page: e19 year: 2016 ident: 10.1016/S2214-109X(20)30035-8_bib32 article-title: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement publication-title: Lancet doi: 10.1016/S0140-6736(16)30388-9 |
| SSID | ssj0000993277 |
| Score | 2.5841699 |
| Snippet | The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal (SDG) 3.4.... Background: The reduction by a third of premature non-communicable disease (NCD) mortality by 2030 is the ambitious target of Sustainable Development Goal... |
| SourceID | doaj proquest pubmed crossref elsevier |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e511 |
| Title | Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990–2017: a population-based study |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2214109X20300358 https://dx.doi.org/10.1016/S2214-109X(20)30035-8 https://www.ncbi.nlm.nih.gov/pubmed/32199120 https://www.proquest.com/docview/2381621239 https://doaj.org/article/b13cad8f7a6f49d18dc74a8a0b29c841 |
| Volume | 8 |
| WOSCitedRecordID | wos000521078600023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2214-109X dateEnd: 20231231 omitProxy: false ssIdentifier: ssj0000993277 issn: 2214-109X databaseCode: DOA dateStart: 20130101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2214-109X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000993277 issn: 2214-109X databaseCode: M~E dateStart: 20130101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LbtUwELWgYoGEKt7cApWRWICEqeM4ic0OUCs2VEiAlJ01fkS6CNKr--iy4g9Y9A_7JXjsJLQLdFmwySLOJI5n4jmOZ84Q8lxwH4KoLFNgNZPOSgY6ABOiCwDRiLx1qdhEc3ys2lZ_ulTqC2PCMj1wHrgDW5QOvOoaqDupfRR2jQQF3ArtVEpZF7zRlxZT3zLuKUUquyhEIeNco9s_6TsHn6eTLwR_WSbaRnXFMSX-_iv-6W_4M_mho9tkdwCQ9G3u-B1yLfR3ya38943mpKJ75FcOdaXzni6WyMq6WQYKWHoZM6Xoj4S5I_6mmF1C-5OeuTFRBNuHXZsVjYiWFrqiqaIELqop9J6ukc0RyUXC6lVs1vzi53n08M0bCnQxFQRj6CA9Tfy198nXo8Mv7z-wofQCc5VWa1bzUMUht8JKKCWHkkOEHq6oleY6-IC88gIKByCddlYHwUPXORsV3HDXhfIB2YmdD48IBVlXuis8Lh2lVrUVXVXWEZV1qvKyCjMix3E3buAlx_IY380UgIbqwq3y1ghukrqMmpHXk9giE3NsE3iHSp0uRl7tdCJamxmszWyzthmpR5MwY-pqnGzjjebbnq4mwQHbZMzyL6LPRtsz8dvHDR3ow8lmZRBu1Yg99Iw8zEY5vV4pMKhN8L3_8dqPyU2B_xlSxNITsrNebsJTcsOdruer5T653rRqP32A8fjx7PA3-oowow |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+premature+avertable+mortality+from+non-communicable+diseases+for+195+countries+and+territories%2C+1990%E2%80%932017%3A+a+population-based+study&rft.jtitle=The+Lancet+global+health&rft.au=Martinez%2C+Ramon&rft.au=Lloyd-Sherlock%2C+Peter&rft.au=Soliz%2C+Patricia&rft.au=Ebrahim%2C+Shah&rft.date=2020-04-01&rft.pub=Elsevier+Ltd&rft.issn=2214-109X&rft.volume=8&rft.issue=4&rft.spage=e511&rft.epage=e523&rft_id=info:doi/10.1016%2FS2214-109X%2820%2930035-8&rft.externalDocID=S2214109X20300358 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2214-109X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2214-109X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2214-109X&client=summon |